Derivatives of 3-methyl-3,6-dihydro-2H-1,2-oxazine-6-carboxylic acid prepared by regioselective hetero Diels-Alder reaction of arylnitroso compounds with sorbic acid were used for solid-phase synthesis of a library of derivatives that included modification of carboxylic group, dihydroxylation of double bond and cleavage of N-O bond. Derivatives of 2,3,4-trihydroxyhexanoic acid obtained from 3,6-dihydro-2H-1,2-oxazines after double bond dihydroxylation and N-O cleavage were used for simple and stereoselective formation of chiral lactones derived from 3,4-dihydroxydihydrofuran-2(3H)-one. The final compounds obtained as a mixture of stereoisomers were analyzed with use of chiral HPLC and SFC. HPLC analyses were not successful for all derivatives or required lengthy chromatography. On the other hand SFC afforded much shorter analyses and was effective for all studied derivatives. The method of synthesis and analysis is thus suitable for future study of stereoselective synthesis of lactones and other derivatives from single oxazine derivatives and application of highthroughput synthesis on solid-support and combinatorial chemistry.
Introduction
3,6-Dihydro-1,2-oxazine belongs to very interesting scaffold, which is compatible with a wide variety of transformations. These cycloadducts have become valuable key intermediates for the synthesis of biologically interesting molecules especially because they offer plethora of modification possibilities including N-O bond cleavage mediated by titanocene(III) chloride, [1] Mo (CO) 6 [2;3] or other reducing agents providing ready access to 1,4-amino alcohols. [4;5] Before or after N-O reduction, the double bond can be hydroborated or oxidized to give epoxides, diols or even diacids after complete cleavage. Epoxidation, hydroboration [6] or hydroxylation [7] has been used for the synthesis of aminosugars. Alternatively, the alkene has been used in a domino metathesis reaction to give isoxazolopyridines. [8] Additional modifications of 3,6-dihydro-1,2-oxazines have been reviewed and include applications for the syntheses of various biologically important compounds including carbocyclic nucleosides, azasugars, tropane alkaloids and other natural compounds. [9] Thus, although chemical transformations of oxazines have been extensively explored in solution, the only reported solid phase based oxazine conversions were described by Krchnak et al, who described acid-mediated cleavage of oxazine C-O bond. [10;11] Apart from wide variety of interesting products, 3,6-dihydro-1,2-oxazine derivatives were also used for the preparation of lactones via quite complex synthesis. [12;13] The lactone moiety occurs in wide range of natural biologically active compounds including compounds such as vitamin C, [14] kavain having anxiolytic and sedative effects, [15] helenalin, [16] the anti-inflammatory active component of Arnica or parthenolide [17;18] with antiinflammatory, anticancer and antiviral properties, contained in feverfew (Pyrethrum parthenium).
Due to their biological properties, synthetic methods compatible with preparation of structurally varied lactones are of considerable interest. Many synthetic approaches to lactones have been reported [19] [20] [21] [22] [23] but only a few were developed for solid-phase chemistry [24] [25] [26] that could additionally facilitate the extensions of related molecular diversity via application of combinatorial chemistry in high throughput mode. In addition none of these solid-phase methods employs the oxazine core as the lactone precursor. Here we report the solid-phase syntheses of 3,6-dihydro-1,2-oxazines derived from hetero Diels-Alder (HDA) reactions of sorbic acid and arylnitroso derivatives and their further transformation to 3,6-dihydro-1,2-oxazines and their 4,5-dihydroxyanalogues, as well as stereoselective conversion to 3,4-dihydroxy-ɤ-lactones. Development of chiral separation of enantiomeric products with use of chiral HPLC and SFC, that would facilitate development of stereoselective synthetic routes in future, is also described.
Results and Discussion Synthesis
The synthesis of the final ɤ-lactones 8(R The synthesis of the starting oxazine system 5(R 1 ,X) was adopted from that described previously. [27] However, the products were diversified by incorporation of Rink resin-bound amino acid or dipeptide (Fig 1) . The amino group of the Rink linker or immobilized amino acids 1(R 1 ) was acylated by fluoroaromatic carboxylic acids using traditional HOBt active esters to give derivative 2(R The final step, the formation of the lactone ring, was performed by cyclization of trihydroxy derivatives 7(R 1 ,X) in acidic cleavage cocktail during its releasing from the resin. The final ) from the resin (see Fig 5) . The study was focused on the synthesis development with not full combination of used building blocks. The summary of the prepared compounds is showed in Figs 2, 4 and 5.
Stereochemistry
We supposed that the steric hindrance of carboxylic and methyl group in oxazine 5(R 1 ,X) directed the dihydroxylation with osmium tetraoxide to the opposite part of the molecule to afford dihydroxyderivative 6(R 1 ,X) (and subsequently 7(R 1 ,X)) with high stereoselectivity. Taking this fact into account subsequent cyclization of carboxylic group and γ-hydroxygroup of derivative 7(R 1 ,X) can afford the final lactone 8(R 1 ,X) in major form having the two hydroxyl groups in cis-configuration (Fig 6) .
Because the oxazine 5(R 1 ,X) is formed as the racemic mixture, we should get mainly two enantiomers of dihydroxyderivative 6(R 1 ,X) and finally two enantiomers of lactone 8(R 1 ,X). Due to this fact it is finally possible to expect the formation of lactones predominantly in mixture of only two enantiomers, where stereoisomery comes from HDA reaction itself. Stereoselectivity of the final lactones is thus directed only in step of HDA reaction. To confirm the stereoselectivity of lactone 8(R 1 ,X) formation, we did the ROESY NMR experiment for derivative 8(1,1) which showed the spatial interaction between H A and H B protons (Fig 7) , giving the evidence of cis-configuration. 
Chiral separation
For the checking of the optical purity as well as a stereoselective control of the reaction it is necessary to develop suitable analytical methods, which must be i) able to determine the optical purity of final products after isolation ii) able to determine optical purity of compound of interest in crude reaction mixtures to give response for modification of the conditions for possible stereoselective synthesis iii) fast enough to reflect synthetic quickness and high-throughput approach and thus enable rapid optimization of reaction conditions as well as rapid control of optical purity.
In previous report we studied in detail analytical conditions for chiral analysis of various 3,5-dihydro-1,2-oxazines prepared on solid support. [29] For study of enantiomers resolution of oxazines 11(R Table 1 ). The analytical conditions were first optimized for pure compounds to achieve sufficient resolution and as fast analysis as possible. In the beginning of the study we performed screening of columns by mixture of hexane/alcohol. For this purpose ethanol and isopropanol were tested and the results showed the use of ethanol with lower elution solvent power more suitable for the analysis. Ethanol provided good enantiomers separations, but long time analysis was needed. While, the use of isopropanol decreased the time of analysis, but the resolution was too low. From this reason ethanol was used for majority of the HPLC analyses. Very important role was played by TFA used as an additive. In all cases mobile phase without this additive afforded the analysis with broad and hardly detectable peaks. However, the adding of TFA to the mobile phase significantly improved the separation and peak shapes.
When comparing columns IA and ID, which have the same dimension, the column IA provided the elution of the sample in lower retention time. Therefore column IA was more preferable in the majority of the separations. Since in one case of derivative 12(4,1,1) enantiomers were not resolved with any of these two columns, another column using 3-chloro-4-methylaniline as a sorbent (column IF-see Fig 8) , successfully applied in separation of lactones 8(R 1 ,X) (see later) was included to the screening. Unfortunately, the sufficient resolution was accomplished neither with this column. The HPLC conditions for chiral separation tested for selected derivatives of the compounds 11(R Table 1 .
For future development of conditions for stereoselective synthesis of the mentioned oxazines it is necessary to have an analytical method robust and fast enough also for monitoring of stereoisomers in the reaction. Therefore we tried to apply the developed analytical ) we found out, that the separation conditions were suitable also for crude mixtures, when impurities were sufficiently separated (Fig 9) .
The HPLC separation afforded good separation for all lactones and two oxazines mixtures. For three racemic mixtures the Rs was lower than standard 1.5 and one derivative was not separated at all ( Table 1 ). The time of the analyses was 22-60 minutes, what limits the applicability in development and monitoring of stereoselective synthesis in high-throughput mode-main advantage of solid-phase synthesis. Therefore we decided to apply supercritical fluid chromatography (SFC), modern method for easier and fast separation especially of chiral compounds. For the optimization study we chose the same sorbent as for HPLC based on amylose. Methanol was used as the organic modifier. The suitable resolution and elution was achieved with alcohol content about 15-60%. As the additive 0.1% of DEA/TFA mixture was supplemented to the mobile phase. Unlike the HPLC, where the derivative 12(4,1,1) was not possible to separate, the SFC method provided the separation of enantiomers with Rs factor 1.83 (see Table 2 ).
The 
Conclusion
We used solid supported hetero-Diels-Alder cycloaddition of arylnitroso derivatives and sorbic acid for the synthesis of oxazine derivatives and their subsequent transformation. The stereoselective hydroxylation of double bond of oxazine cycle following by N-O cleavage provided trihydroxy precursors for ɤ-lactones cyclization. The lactone formation is keeping configuration of all chiral centers and therefore the method is suitable for stereoselective synthesis of substituted 3,4-dihydroxy-ƴ-lactones. The same precursors are then used for synthesis of derivatives of 3,6-dihydro-1,2-oxazines. For stereoselectivity control analytical methods based on chiral HPLC and SFC separation were developed and compared. While the HPLC analyses suffer from the low versatility of chiral columns, longer time of analysis and generally lower resolution, SFC was found to be able separate all derivatives in very short time with acceptable resolution and application of only two sorbents. The synthetic and analytical conditions are thus possible to use for development of stereoselective synthesis of oxazine as well as ƴ-lactone derivatives and the products of their transformation on solid support.
Materials and Methods Apparatus
HPLC chiral analyses were performed using an HPLC Alliance Waters e2695 system equipped with a Waters PDA detector 2998 and several 250 x 4.6 mm (i.d.) Chiracel columns, including CHIRALPAK IA, CHIRALPAK ID and CHIRALPAK IF with sorbents based on amylose immobilized on 5 μm silica particles. Different mobile phase systems were investigated in this study. The eluting strength of the mobile phases was adjusted in such a way so that each racemic compound could be eluted within a reasonable time window. The proportion of each mobile phase component or mobile phase additive was always measured by volume. The chromatographic runs were performed at a flow rate of 1.0 ml/min and at a column temperature of 25˚C.
SFC chiral analyses were performed using an Acquity UPC2 system (Waters) consisting of a binary solvent manager, sample manager, column manager, column heater, convergence manager, PDA detector 2998, QDa mass detector and 4.6x100mm, 3 μm particle chiral analytical columns CHIRALPAK IA3 and CHIRALPAK ID3,. The eluting strength of the mobile phases was adjusted in such a way so that each racemic compound could be eluted within a reasonable time window. The chromatographic runs were performed at a flow rate of 2.5 ml/ min and at a column temperature of 38˚C.
LC/MS analyses were performed by UHPLC/MS using an Acquity UHPLC chromatograph equipped with a PDA detector and a single quadrupole mass spectrometer (Waters) with an X-Select C18 column at 30˚C at a flow rate of 600 μl min -1 . The mobile phase consisted of (A) 0.01 M ammonium acetate in water and (B) acetonitrile, with B linearly programmed to shift from 10% to 80% over the course of 2.5 min and then maintained this concentration for 1.5 min. The column was re-equilibrated at 10% B for 1 min. The ESI ionization operated at a discharge current of 5 μA, a vaporizer temperature of 350˚C and a capillary temperature of 200˚C.
Purification was performed by semipreparative HPLC using a Waters 1500 series HPLC equipped with an Autosampler 2707, a Binary HPLC pump 1525, a Waters Photodiode Array Detector 2998 and a Waters Fraction Collector III with a 20x100 mm, 5 μm particle YMC C18 reverse phase column. The mobile phase consisted of acetonitrile and a 10 mM aqueous ammonium acetate gradient over 6 min.
NMR spectra were measured in DMSO-d6 using a Jeol ECX-500SS (500 MHz, HRMS analysis was performed using an Orbitrap Elite high-resolution mass spectrometer (Thermo Fischer Scientific, MA,USA) operating in positive full scan mode (120 000 FWMH) with a mass range of 200-900 m/z. The settings for electrospray ionization were as follows: an oven temperature of 300˚C, a sheath gas of 8 arb. units and a source voltage of 1.5 kV. The acquired data were internally calibrated with diisooctyl phthalate as a contaminant in methanol (m/z 391.2843). Samples were diluted to a final concentration of 20 μmol l -1 with 0.1% formic acid in water and methanol (50: 50, v/v). The samples were injected by direct infusion into the mass spectrometer.
Sample preparation
Samples for UHPLC/MS analysis were prepared by treatment of the analytical sample of the resin (~5 mg) with cleavage cocktail 50% TFA in DCM for 30 min. The cleavage cocktail was evaporated by a stream of nitrogen and sample was extracted into 1 mL of 50% MeOH/water and analyzed by LC/MS. For HPLC purification of final compounds, resin (~0.5 g) was treated with cleavage cocktail 50% TFA in DCM for 1 hour. The solution was collected and the resin was washed 3 times Crude samples for HPLC chiral analysis and SFC chiral analysis were prepared by cleaving 20 mg of dried resin in 50% TFA in DCM for 30 minutes and evaporating the solvent with a stream of nitrogen. The samples were then extracted into 1 mL of HPLC grade EtOH/hexane (1:1) or EtOH/THF (1:1) for MS analysis and filtered before being used for chiral analysis.
Pure samples for HPLC chiral analysis and SFC chiral analysis were prepared at a concentration of 1mg/mL in HPLC grade EtOH/hexane (1:1).
Synthetic procedures
Amino acid (dipeptide) linker (resin 1(R 1 )). Rink resin (1 g) was washed 3x with DCM and 3 x with DMF, treated with 50% piperidine in DMF and the slurry was shaken for 15 min. The resin was washed 5 x with DMF and 3 x with DCM and the solution of amino acid (2 mmol), HOBtÁH 2 O (2 mmol) and DIC (2 mmol) in DMF/DCM (10 mL, 1:1) was added and the slurry was shaken for 3 h. The resin was washed 3 x with DMF and 3 x with DCM. For the synthesis of dipeptide 1(4) the procedure was repeated to bind the second amino acid.
Acylation with carboxylic acid (resin 2(R 1 ,X)). The resin 1(R 1 ) (1 g) was washed 3 x with DCM and 3 x with DMF and treated with 50% piperidine in DMF for 15 min. The resin was washed 5 x with DMF and 3 x with DCM and a solution of carboxylic acid (3 mmol), HOBtÁH 2 O (3 mmol) and DIC (3 mmol) in DMF (10 mL) was added. The resin slurry was shaken overnight. Then the resin was washed 3 x with DMF and 3 x with DCM.
Resins 2(1,1) and 2(1,2) were prepared according to previously described procedure. [9] Substitution with hydroxylamine hydrochloride (resin 3(R 1 ,X)). Resins 3(R 1 ,1) were prepared according to previously described procedure. [27] The appropriate resin 3(R 1 ,2) was prepared from appropriate resin 2(R 1 ,2) (1 g), which was washed 3x with DCM and 3 x with DMSO and treated with a solution of NH 2 OHÁHCl (14 mmol) and DBU (6 mmol) in DMSO (10 mL). The slurry was shaken at 80˚C for 20 h. The resin was washed 3 x with DMSO, 3 x with DMF and 3 x with DCM.
HDA reaction with sorbic acid (resin 5(R 1 ,X)). Resin 3(R 1 ,X) (1 g) was washed 3 x with DCM and treated with a solution of sorbic acid (3.5 mmol) and TBAPI (1.75 mmol) in DCM (10 mL). The slurry was shaken for 3 h at room temperature. The resin was washed 3 x with DCM, 3 x with THF and 3 x with DCM. N-(2-((3-Amino-3-oxopropyl)amino)-2-oxoethyl)-4-((1-(3,4-dihydroxy-5-oxotetrahydrofuran-2-yl)ethyl)amino)-3-nitrobenzamide 8(4,1) . Yield 20 mg (30%). Amino-3-oxopropyl)carbamoyl)-2-nitrophenyl)-4,5-dihydroxy-3-methyl-Npropyl-1,2-oxazinane-6-carboxamide 11(3,1,1) . Yield 26 mg (39%). 2-(4-((2-Amino-2-oxoethyl)carbamoyl)-2-nitrophenyl)-N-benzyl-4,5-dihydroxy-3-methyl-1,2-oxazinane-6-carboxamide 11(2,1,2) . Yield 25 mg (34%). 4-(4,5-Dihydroxy-3-methyl-6-(piperidine-1-carbonyl)-1,2-oxazinan-2-yl)-3-nitrobenzamide 11(1,1,3) . Yield 25 mg (41%). 2-(4-((2-((3-Amino-3-oxopropyl)amino)-2-oxoethyl)carbamoyl)-2-nitrophenyl)-4,5-dihydroxy-3-methyl-N-propyl-1,2-oxazinane-6-carboxamide 11(4,1,1) . Yield 35 mg (46%). N-(3-((2-Amino-2-oxoethyl)amino)-3-oxopropyl)-6-(4,5-dihydroxy-3-methyl-6-(piperidine-1-carbonyl)-1,2-oxazinan-2-yl)nikotinamide 11(4,2,3) . Yield 12 mg (16%). Amino-3-oxopropyl)carbamoyl)-2-nitrophenyl)-3-methyl-N-propyl-3,6-dihydro-2H-1,2-oxazine-6-carboxamide 12(3,1,1) . Yield 22 mg (35%). ; found 420.1900. The structure of the compound is available in Supporting Information-S44 Fig.  4-(3-Methyl-6-(piperidine-1-carbonyl)-3,6-dihydro-2H-1,2-oxazin-2-yl)-3-nitrobenzamide 12(1,1,3) . Yield 17 mg (31%). (3,4-dihydroxy-5-oxotetrahydrofuran-2-yl)ethyl)amino)-3-nitrobenzamide 8(4,1) . (TIF) S12 Fig.   1 H NMR spectrum of 6- ((1-(3,4-Dihydroxy-5-oxotetrahydrofuran-2-yl) 3-methyl-1,2-oxazinane-6-carboxamide 11(1,2,2 -2-(5-carbamoylpyridin-2-yl)-4,5-dihydroxy-3-methyl-1,2-oxazinane-6-carboxamide 11(1,2,2 N-(3-((2-Amino-2-oxoethyl)amino)-3-oxopropyl)-6-(4,5-dihydroxy-3-methyl-6-(piperidine-1-carbonyl)-1,2-oxazinan-2-yl)nikotinamide 11  (4,2,3) . 3-methyl-N-propyl-3,6-dihydro-2H-1,2-oxazine-6-carboxamide 12(2,2,1) . (TIF) S38 Fig.   1   H NMR spectrum of N-Benzyl-2-(5-carbamoylpyridin-2-yl)-4,5-dihydroxy-3-methyl-1,2-oxazinane-6-carboxamide 12(1,2,2 Fig. 2-(4-((3-Amino-3-oxopropyl)carbamoyl)-2-nitrophenyl)-3-methyl-N-propyl-3,6-dihydro-2H-1,2-oxazine-6-carboxamide 12(3,1,1. ) (TIF) 
N-(3-Amino-3-oxopropyl)-4-((1-(3,4-dihydroxy-5-oxotetrahydrofuran-2-yl)ethyl) amino)-3-nitrobenzamide 8(3,1). Yield 15 mg (25%).
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